MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Valeant Pharmaceuticals Intl Company Profile (TSE:VRX)

Consensus Ratings for Valeant Pharmaceuticals Intl (TSE:VRX) (?)
Ratings Breakdown: 4 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.20)
Consensus Price Target: C$147.67

Analysts' Ratings History for Valeant Pharmaceuticals Intl (TSE:VRX)
Show:
DateFirmActionRatingPrice TargetActions
5/24/2016RBC CapitalReiterated RatingSector PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2016ScotiabankReiterated RatingSector PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2016TD SecuritiesBoost Price TargetHoldC$45.00 -> C$110.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/19/2015Citigroup Inc.Reiterated RatingOverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/2/2015Goldman SachsDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/27/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha